Monday, September 21, 2009

Verichip shares jump after H1N1 patent licence win

Interesting little story. It deserves widespread attention.

Shares of VeriChip Corp tripled after the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans.

Implanted, knowlingly or otherwise?

The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses, and biological threats such as methicillin-resistant Staphylococcus aureus, VeriChip said in a statement.

The technology will combine with VeriChip's implantable radio frequency identification devices to develop virus triage detection systems. The triage system will provide multiple levels of identification -- the first will identify the agent as virus or non-virus, the second level will classify the virus and alert the user to the presence of pandemic threat viruses and the third level will identify the precise pathogen, VeriChip said in a white paper published May 7, 2009.

What else can the chip do? What else can it identify? It could be adjusted after implant quite easily. Then what could the chip do? What could the chip inform the "user" of ? And who exactly is the "user"?

Shares of VeriChip were up 186 percent at $3.28 Monday late afternoon trade on Nasdaq. They had touched a year high of $3.43 earlier in the session.

Any other questions? Feel free to add them

2 comments:

  1. I was going to ask what a n appropriate dip would be for these chips but I suppose we all know that would be sour grapes Huh

    ReplyDelete
  2. hey silv:
    a sour grape dip sounds gross.

    But,I am not a coincidence theorist and that cannot be a coincidence

    ReplyDelete

TROLLS &SPAM WILL BE DELETED WITHOUT HESITATION
KEEP IT RELEVANT. NO PERSONAL ATTACKS